SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

North America Injectable Drug Delivery Market 2017: Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 - Research and Markets
[December 07, 2017]

North America Injectable Drug Delivery Market 2017: Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 - Research and Markets


The "North America Injectable Drug Delivery Market: Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

The North America Injectable Drug Delivery Market is accounted to reach USD 354.53 billion by 2024 from USD 154.05 billion in 2016, at a CAGR of 5.4% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others), rapidly increasing aging population and the subsequent rise in chronic conditions, rising demand of self injection devices, technological advancement and innovations in drug delivery market.

The North America injectable drug delivery market is segmented on the basis of type, application, usage pattern, mode administration, end user, and distribution channel. The North America injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.

Injectable drug delivery device market is segmented into hormonal disorers, oncology, autoimmune diseases, orphan diseases and other diseases on the basis of application.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.


On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.

The key market players for North America Injectable Drug Delivery Devices Market are listed below:

  • Pfizer and Baxter International, Inc.
  • Gerresheimer AG
  • Schott AG, Alkermes Plc.
  • Eli Lilly and Company
  • Sandoz
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • Bespak, Antares Pharma
  • Elcam Medical
  • Haselmeier
  • Mylan N.V.
  • Novo Nordisk
  • Owen Mumford Ltd,Sanofi
  • West Pharmaceutical Services, Inc
  • Ypsomed Holding AG.

Key Topics Covered:

1 Introduction

2 Market Segmentation

3 Market Overview

4 Executive Summary

5 Premium Insights

6 North America Injectable Drug Delivery Market: by Type

7 North America Injectable Drug Delivery Market: by Usage Pattern

8 North America Injectable Drug Delivery Market, Mode Administration

9 North America Injectable Drug Delivery Market: by End User

10 North America Injectable Drug Delivery Market: Geography

11 North America Injectable Drug Delivery Market: Company Profiles

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/8chfbt/north_america?w=4


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy